跳至主要内容
临床试验/NCT01785732
NCT01785732Unknown不适用

Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study)

The Hospital District of Satakunta1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Office blood pressure

研究概览

简要总结

Hypertension is a major risk factor for stroke and cardiovascular mortality. Catheter- based renal denervation causes substantial and sustained blood- pressure reduction in patients with resistant hypertension.

The purpose of RENSYMPIS is to study the effects of renal denervation on:

  1. Cardiovascular function
  2. Metabolic factors
  3. Inflammatory and endocrine factors
  4. Coagulation
  5. Sleep

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resistant Hypertension (systolic blood pressure >160mmHg and 3 or more antihypertensive agents in use)
  • Age 30- 69 years
  • Written informed consent

排除标准

  • Secondary hypertension
  • Pseudohypertension
  • Pregnancy
  • Renal insufficiency (GFR <45ml/min)
  • Clinically significant stenotic valvular disease
  • Oral anticoagulation
  • CCS III-IV symptoms or CABG/PCI in previous 6 months
  • Prior stroke
  • Contrast agent allergy
  • inappropriate renal artery anatomy (< 4mm diameter, < 20mm length)

结局指标

主要结局

Office blood pressure

时间窗: 2 years

次要结局

  • Ambulatory blood pressure(2 years)
  • Insulin resistance(2 years)
  • Endothelial function(2 years)

研究者

发起方
The Hospital District of Satakunta
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验